Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Aveiro – page 5

93 clinical trials in Aveiro, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Aveiro at a glance
93
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

93 trials in Aveiro

Open in trial search

Obesity

Not recruiting

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Effects of Itepekimab for Patients with Chronic Rhinosinusitis Without Nasal Polyps

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Colitis ulcerative

Not recruiting

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Aveiro

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular conditions, including studies of new treatments for acute myocardial infarction and hypertrophic cardiomyopathy. Researchers are evaluating novel therapies for stroke prevention and heart-related complications.

  • Hypertrophic Cardiomyopathy Treatment
  • Stroke Prevention Therapies
  • Acute Myocardial Infarction Management

Advanced studies targeting improved outcomes in patients with various cardiac conditions through innovative therapeutic approaches.

02 Respiratory Medicine

Research initiatives addressing chronic respiratory conditions, with particular emphasis on chronic rhinosinusitis and COPD. Studies are evaluating new therapeutic agents for managing symptoms and improving patient quality of life.

  • Chronic Rhinosinusitis Treatment
  • COPD Management
  • Nasal Polyps Therapy

Comprehensive trials exploring both symptomatic relief and long-term disease modification strategies.

03 Metabolic Disorders

Clinical investigations into metabolic conditions, focusing on obesity, diabetes, and related complications. Studies are examining new treatments for hypertriglyceridemia and innovative approaches to weight management.

  • Obesity Treatment
  • Diabetic Complications
  • Lipid Management

Groundbreaking research aimed at developing effective therapies for metabolic disorders and their associated complications.

04 Hematology Research

Studies investigating treatments for blood disorders, particularly focusing on conditions like Paroxysmal Nocturnal Hemoglobinuria and various forms of neutropenia. Researchers are evaluating novel therapeutic approaches.

  • PNH Treatment Development
  • Neutropenia Management
  • Blood Disorder Therapies

Innovative clinical trials exploring new treatment options for rare and chronic blood conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.